Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion

Roshan V Tiwari1, Ashley N Polk2, Hemlata Patil1

  • 1Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA.

AAPS Pharmscitech
|November 18, 2015
PubMed

Insights

Developing pediatric oral formulations presents taste-masking challenges. This study introduces a rat model as a cost-effective alternative for assessing taste-masking efficacy in pediatric drug development.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Pediatric Formulations

Background:

  • Taste masking of bitter active pharmaceutical ingredients (APIs) is crucial for pediatric oral formulations.
  • Existing taste-masking techniques face limitations with pediatric excipient constraints.
  • Hot-melt extrusion (HME) offers a viable solution for taste masking bitter APIs.

Purpose of the Study:

  • To develop taste-masked caffeine citrate extrudates using HME.
  • To evaluate a single bottle-test rat model for taste assessment efficacy.
  • To establish a cost-effective alternative to human taste panels and electronic tongues for pediatric formulations.

Main Methods:

  • Hot-melt extrusion (HME) was employed to create taste-masked caffeine citrate extrudates.
  • A single bottle-test rat model was utilized to measure solution consumption.
  • Consumption volumes of taste-masked solutions were compared against the pure API.

Main Results:

  • Taste-masked caffeine citrate extrudates were successfully developed via HME.
  • The rat model demonstrated applicability in assessing taste-masking effectiveness.
  • Consumption data from the rat model indicated successful taste mitigation.

Conclusions:

  • HME is effective for developing taste-masked pediatric formulations.
  • The single bottle-test rat model shows promise as a low-cost taste assessment method.
  • This rat model can aid in selecting palatable pediatric formulations, offering an alternative to expensive human taste panels.

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
403
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
485
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
761